EKF Diagnostics (LON:EKF) Stock Price Passes Above 200-Day Moving Average of $42.06

EKF Diagnostics Holdings plc (LON:EKFGet Rating)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 42.06 ($0.51) and traded as high as GBX 49.25 ($0.60). EKF Diagnostics shares last traded at GBX 47.70 ($0.58), with a volume of 325,757 shares trading hands.

EKF Diagnostics Trading Down 2.4 %

The company has a quick ratio of 1.77, a current ratio of 2.50 and a debt-to-equity ratio of 2.21. The company has a market cap of £217.00 million and a PE ratio of 2,385.00. The stock’s 50 day moving average is GBX 46.01 and its 200-day moving average is GBX 42.06.

EKF Diagnostics Increases Dividend

The company also recently disclosed a dividend, which was paid on Thursday, December 1st. Shareholders of record on Thursday, November 3rd were given a dividend of GBX 1.20 ($0.01) per share. This is a boost from EKF Diagnostics’s previous dividend of $1.10. The ex-dividend date was Thursday, November 3rd. This represents a yield of 2.35%. EKF Diagnostics’s payout ratio is 55.00%.

EKF Diagnostics Company Profile

(Get Rating)

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.

Further Reading

Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.